Binding of the Microbial Cyclic Tetrapeptide Trapoxin A to the Class I Histone Deacetylase HDAC8.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  ACS Chemical Biology

• Publication date

  2017-08-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/acschembio.7b00330PMID 28846375PMCID PMC5600712
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Discovery of Highly Selective Inhibitors of the Immunoproteasome Low Molecular Mass Polypeptide 2 (LMP2) Subunit.

  2017cited by this paper
• The Substrate Specificity of Sirtuins.

  2016cited by this paper
• Histone deacetylase 6 structure and molecular basis of catalysis and inhibition

  2016cited by this paper
• General Base-General Acid Catalysis in Human Histone Deacetylase 8.

  2016cited by this paper
• Structural and Functional Influence of the Glycine-Rich Loop G302GGGY on the Catalytic Tyrosine of Histone Deacetylase 8.

  2016cited by this paper
• Molecular Basis for Histone Acetyltransferase Regulation by Binding Partners, Associated Domains, and Autoacetylation.

  2016cited by this paper
• Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders

  2014cited by this paper
• Structural basis of the antiproliferative activity of largazole, a depsipeptide inhibitor of the histone deacetylases.

  2011cited by this paper
• Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes.

  2011cited by this paper
• Acetylation of Metabolic Enzymes Coordinates Carbon Source Utilization and Metabolic Flux

  2010cited by this paper
• (2S,3S)-2,3-Epoxy-3-trimethylsilylpropanal as a New Conjunctive Reagent.

  2010cited by this paper
• Regulation of Cellular Metabolism by Protein Lysine Acetylation

  2010cited by this paper
• Clinical development of histone deacetylase inhibitor romidepsin.

  2010cited by this paper
• Rise of the Rival

  2010cited by this paper
• Activation and Inhibition of Histone Deacetylase 8 by Monovalent Cations*

  2009cited by this paper
• Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions

  2009cited by this paper
• Total synthesis and molecular target of largazole, a histone deacetylase inhibitor.

  2008cited by this paper
• Structural studies of human histone deacetylase 8 and its site-specific variants complexed with substrate and inhibitors.

  2008cited by this paper
• Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8–substrate complex

  2007cited by this paper
• Histone Deacetylase Inhibitors: Overview and Perspectives

  2007cited by this paper
• Catalytic activity and inhibition of human histone deacetylase 8 is dependent on the identity of the active site metal ion.

  2006cited by this paper
• Femtomolar Transition State Analogue Inhibitors of 5′-Methylthioadenosine/S-Adenosylhomocysteine Nucleosidase from Escherichia coli*

  2005cited by this paper
• Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis.

  2004cited by this paper
• Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases.

  2004cited by this paper
• Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor.

  2004cited by this paper
• Histone deacetylases (HDACs): characterization of the classical HDAC family.

  2003cited by this paper
• FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases.

  2002cited by this paper
• Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin.

  2001cited by this paper
• Arginase: a binuclear manganese metalloenzyme.

  2000cited by this paper
• Acetylation of Histones and Transcription-Related Factors

  2000cited by this paper
• Acetylation: a regulatory modification to rival phosphorylation?

  2000cited by this paper
• Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors

  1999cited by this paper
• Structure of a unique binuclear manganese cluster in arginase

  1996cited by this paper
• Design and Synthesis of Novel Protease Inhibitors. Tripeptide α′, β′-Epoxyketones as Nanomolar Inactivators of the Proteasome.

  1996cited by this paper
• Rates of Uncatalyzed Peptide Bond Hydrolysis in Neutral Solution and the Transition State Affinities of Proteases

  1996cited by this paper
• A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p

  1996cited by this paper
• Synthesis of Natural and Modified Trapoxins, Useful Reagents for Exploring Histone Deacetylase Function

  1996cited by this paper
• A synthetic route to anti aminoalkyl epoxides by stereocontrolled reductive amination of ketoepoxides

  1994cited by this paper
• Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase.

  1993cited by this paper
• Isolation and structural elucidation of new cyclotetrapeptides, trapoxins A and B, having detransformation activities as antitumor agents.

  1990cited by this paper
• Stereoselective additions to α,β-epoxy-aldehydes; the formation of “non-chelation controlled” products

  1987cited by this paper
• Mechanism of carboxypeptidase A: hydration of a ketonic substrate analogue.

  1987cited by this paper
• Stereoselective Additions to α,β-Epoxyaldehydes. The Formation of “Non- Chelation Controlled” Products.

  1987cited by this paper
• Binding of a possible transition state analogue to the active site of carboxypeptidase A.

  1985cited by this paper
• Antiproteolytic aldehydes and ketones: substituent and secondary deuterium isotope effects on equilibrium addition of water and other nucleophiles.

  1977cited by this paper
• ACETYLATION AND METHYLATION OF HISTONES AND THEIR POSSIBLE ROLE IN THE REGULATION OF RNA SYNTHESIS.

  1964cited by this paper
• Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors

  year unknowncited by this paper

• Investigation of the histone deacetylase inhibitor potential of phorbazole analogues.

  2025cites this paper
• Preclinical Characterization of SDFZ‐8, a Highly Potent HDAC1 Inhibitor, for Cancer Immunotherapy

  2025cites this paper
• Natural histone deacetylase inhibitions from legumes: Exploring epigenetics modulation through systems biology.

  2025cites this paper
• New potent N‐hydroxycinnamamide‐based histone deacetylase inhibitors suppress proliferation and trigger apoptosis in THP‐1 leukaemia cells

  2025cites this paper
• Peptide-based inhibitors of epigenetic proteins.

  2025cites this paper
• Chemical Versatility in Catalysis and Inhibition of the Class IIb Histone Deacetylases.

  2024cites this paper
• Influence of heterochirality on the structure, dynamics, biological properties of cyclic(PFPF) tetrapeptides obtained by solvent-free ball mill mechanosynthesis

  2024cites this paper
• Synthesis and Evaluation of 9-epi-Koshidacin B as Selective Inhibitor of Histone Deacetylase 1.

  2024cites this paper
• Distribution and diversity of classical deacylases in bacteria

  2024influential citation
• Evaluation of a Covalent Library of Diverse Warheads (CovLib) Binding to JNK3, USP7, or p53

  2024cites this paper
• Biological function and small molecule inhibitors of histone deacetylase 11.

  2024cites this paper
• The role of class IIa histone deacetylases in regulating endothelial function

  2023cites this paper
• Utilization of AlphaFold models for drug discovery: Feasibility and challenges. Histone deacetylase 11 as a case study

  2023cites this paper
• Progress in discovery and development of natural inhibitors of histone deacetylases (HDACs) as anti-cancer agents.

  2023cites this paper
• The Zinc-Binding Group Effect: Lessons from Non-Hydroxamic Acid Vorinostat Analogs.

  2023cites this paper
• Class I histone deacetylase complex: Structure and functional correlates

  2023cites this paper
• Macrocyclic Octapeptide Binding and Inferences on Protein Substrate Binding to Histone Deacetylase 6.

  2023cites this paper
• Trapoxin A Analogue as a Selective Nanomolar Inhibitor of HDAC11

  2023cites this paper
• Advances in the Histone Acetylation Modification in the Oral Squamous Cell Carcinoma

  2023cites this paper
• Functional Drug Screening of Small Molecule Inhibitors of Epigenetic Modifiers in Refractory AML Patients

  2022cites this paper
• Phage-Assisted, Active Site-Directed Ligand Evolution of a Potent and Selective Histone Deacetylase 8 Inhibitor

  2022influential citation
• Treatment of Toxoplasmosis: An Insight on Epigenetic Drugs

  2022cites this paper
• Rational design and development of HDAC inhibitors for breast cancer treatment.

  2021cites this paper
• Strategies To Design Selective Histone Deacetylase Inhibitors

  2021cites this paper
• X-ray Crystallographic Snapshots of Substrate Binding in the Active Site of Histone Deacetylase 10.

  2021cites this paper
• An update on the emerging approaches for histone deacetylase (HDAC) inhibitor drug discovery and future perspectives

  2021influential citation
• Recent Advances in Small Peptides of Marine Origin in Cancer Therapy

  2021cites this paper
• Redefining the Histone Deacetylase Inhibitor Pharmacophore: High Potency with No Zinc Cofactor Interaction

  2021cites this paper
• Comparative QM/MM Molecular Dynamics and Umbrella Sampling Simulations: Interaction of the Zinc-Bound Intermediate Gem-Diolate Trapoxin A Inhibitor and Acetyl-l-lysine Substrate with Histone Deacetylase 8.

  2021cites this paper
• GNPS-guided discovery of xylacremolide C and D, evaluation of their putative biosynthetic origin and bioactivity studies of xylacremolide A and B

  2021cites this paper
• Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites

  2021cites this paper
• Cyclic Tetrapeptide HDAC Inhibitors with Improved Plasmodium falciparum Selectivity and Killing Profile.

  2021cites this paper
• Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective

  2021cites this paper
• Marine-Derived Secondary Metabolites as Promising Epigenetic Bio-Compounds for Anticancer Therapy

  2020influential citation
• Health-promoting role of dietary bioactive compounds through epigenetic modulations: a novel prophylactic and therapeutic approach

  2020cites this paper
• Recent Advances in Chemical Biology Using Benzophenones and Diazirines as Radical Precursors

  2020cites this paper
• Molecular dynamics study of HDAC8-largazole analogues co-crystals for designing potential anticancer compounds

  2020cites this paper
• OleD Loki as a Catalyst for Hydroxamate Glycosylation

  2020cites this paper
• Natural Products Impacting DNA Methyltransferases and Histone Deacetylases

  2020influential citation
• Thirty years of HDAC inhibitors: 2020 hindsight.

  2020cites this paper
• Histone deacetylases as targets for the treatment of neurodegenerative disorders: Challenges and future opportunities

  2020cites this paper
• Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability

  2020influential citation
• Structural determinants of affinity and selectivity in the binding of inhibitors to histone deacetylase 6.

  2020cites this paper
• Divergent Access to Histone Deacetylase Inhibitory Cyclopeptides via a Late-Stage Cyclopropane Ring Cleavage Strategy. Short Synthesis of Chlamydocin.

  2019cites this paper
• Structure, mechanism, and inhibition of the zinc-dependent histone deacetylases.

  2019cites this paper
• Zinc-dependent Deacetylase (HDAC) Inhibitors with Different Zinc Binding Groups.

  2019cites this paper
• Novel 2, 5-diketopiperazine derivatives as potent selective histone deacetylase 6 inhibitors: Rational design, synthesis and antiproliferative activity.

  2019cites this paper
• HDAC Inhibitors in Acute Myeloid Leukemia

  2019influential citation
• Preparation of a new construct of human histone deacetylase 8 for the crystallization of enzyme-inhibitor complexes.

  2019cites this paper
• A Genetically Encoded, Phage-Displayed Cyclic Peptide Library.

  2019cites this paper
• Kinetic Tuning of HDAC Inhibitors Affords Potent Inducers of Progranulin Expression.

  2019cites this paper
• Peptides as epigenetic modulators: therapeutic implications

  2019cites this paper
• Examining the stability of binding modes of the co-crystallized inhibitors of human HDAC8 by molecular dynamics simulation

  2019cites this paper
• Targeting the Zinc-Dependent Histone Deacetylases (HDACs) for Drug Discovery

  2019cites this paper
• Crystal Structures of Protein-Bound Cyclic Peptides.

  2019cites this paper
• Targeting Metalloenzymes for Therapeutic Intervention.

  2018cites this paper
• Natural Products and Chemical Biology Tools: Alternatives to Target Epigenetic Mechanisms in Cancers.

  2018cites this paper
• Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology.

  2018cites this paper
• Targeting HDAC6 with chemical modulators: catalytic inhibition and beyond

  2018cites this paper
• Oxidation catalysis by iron and manganese porphyrins within enzyme‐like cages

  2018cites this paper
• Total Synthesis of Trapoxin A, a Fungal HDAC Inhibitor from Helicoma ambiens.

  2018cites this paper
• Histone Deacetylase 11 is an ε-N-Myristoyllysine Hydrolase

  2017cites this paper
• Structure–Activity Relationship of Propargylamine‐Based HDAC Inhibitors

  2017cites this paper
• Structural Diversity and Biological Activities of Fungal Cyclic Peptides, Excluding Cyclodipeptides

  2017influential citation